Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: A randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group. - Bastholt,L.; Dalmark,M.; Gjedde,S. (J Clin Oncol, 1996)